Business Description
Hua Medicine
ISIN : KYG4644K1022
Compare
Compare
Traded in other countries / regions
02552.Hong KongHUMDF.USA IPO Date
2018-12-03Description
Hua Medicine is an investment holding company. It is engaged in the development and commercialization of a first-in-class oral drug, Dorzagliatin or HMS5552, for the treatment of Type 2 diabetes. The group majorly operates in the PRC.
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 8.71 | |||||
Equity-to-Asset | 0.06 | |||||
Debt-to-Equity | 1.66 | |||||
Debt-to-EBITDA | -1 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | -3.89 | |||||
Beneish M-Score | -3.62 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 26 | |||||
3-Year EPS without NRI Growth Rate | 20.9 | |||||
3-Year Book Growth Rate | -50.1 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.24 | |||||
Quick Ratio | 6.06 | |||||
Cash Ratio | 5.8 | |||||
Days Inventory | 196.82 | |||||
Days Sales Outstanding | 44.61 | |||||
Days Payable | 371.72 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.9 | |||||
Shareholder Yield % | -8.48 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 48.79 | |||||
Operating Margin % | -377.35 | |||||
Net Margin % | -275.72 | |||||
FCF Margin % | 1150.23 | |||||
ROE % | -106.5 | |||||
ROA % | -15.79 | |||||
ROIC % | -72.07 | |||||
ROC (Joel Greenblatt) % | -158.59 | |||||
ROCE % | -18.42 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Price-to-Owner-Earnings | 1.44 | |||||
PS Ratio | 17.33 | |||||
PB Ratio | 13.19 | |||||
Price-to-Tangible-Book | 20.28 | |||||
Price-to-Free-Cash-Flow | 1.51 | |||||
Price-to-Operating-Cash-Flow | 1.5 | |||||
EV-to-EBIT | -0.33 | |||||
EV-to-EBITDA | -0.4 | |||||
EV-to-Revenue | 0.87 | |||||
EV-to-FCF | 0.08 | |||||
Earnings Yield (Greenblatt) % | -303.03 | |||||
FCF Yield % | 65.85 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:HUMDF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Hua Medicine Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 10.7 | ||
EPS (TTM) ($) | -0.031 | ||
Beta | 0.03 | ||
Volatility % | 0 | ||
14-Day RSI | 0 | ||
14-Day ATR ($) | 0 | ||
20-Day SMA ($) | 0.2028 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range ($) | 0.2028 - 0.2028 | ||
Shares Outstanding (Mil) | 980.52 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Hua Medicine Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Hua Medicine Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Hua Medicine Frequently Asked Questions
What is Hua Medicine(HUMDF)'s stock price today?
The current price of HUMDF is $0.20. The 52 week high of HUMDF is $0.20 and 52 week low is $0.20.
When is next earnings date of Hua Medicine(HUMDF)?
The next earnings date of Hua Medicine(HUMDF) is .
Does Hua Medicine(HUMDF) pay dividends? If so, how much?
Hua Medicine(HUMDF) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |